Streetbeat News

Products Services

ELAB

Elevai Labs, Inc. (ELAB) has acquired an exclusive license for two myostatin muscle loss prevention assets and announced plans to develop these in combination with GLP-1 obesity treatments. This strategic move aims to enhance Elevai Labs' offerings in the healthcare sector, specifically targeting muscle loss prevention and obesity treatment.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:04 pm

AAPL

Apple Inc (AAPL) is set to report Q2 earnings with Wall Street expecting $1.40 EPS and $84.12 billion in revenue, a decrease from last year. Despite a year-to-date decline of 11.53% due to a weak iPhone 15 cycle, analysts suggest optimism for the iPhone 16 cycle and are keen on updates about iPhone sales, services revenue, and AI advancements. Technical indicators show a bearish trend for AAPL stock, but analysts see a 20% upside, with upcoming product launches potentially serving as catalysts.

Portfolio Pulse from Surbhi Jain

May 01, 2024 | 1:03 pm

MBRX

Moleculin Biotech, Inc. has announced the formation of a Scientific Advisory Board to support the development of its drug, Annamycin. This move is aimed at enhancing the drug's development process through expert guidance and insights.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:01 pm

CYTO

Altamira Therapeutics has filed a provisional patent application for its OligoPhore nanoparticles, which use siRNA to target the p65 protein, a key player in cancer and inflammation treatment. This development could mark a significant advancement in therapeutic options for these conditions.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:00 pm

OPXS

Optex Systems has received a $1.5 million order for optical assemblies to support an Enhanced Night Vision Goggle Binocular program. This order highlights the company's role in providing critical components for advanced vision systems used in defense applications.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 1:00 pm

CEI

Camber Energy has been granted U.S. Patent 11,965,924 for its innovative 'Electric Transmission Line Ground Fault Prevention Systems Using Multi-Parameter Monitoring'. This patent underscores the company's commitment to enhancing electrical transmission safety and efficiency through advanced technology.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 12:56 pm

ONDS

Ondas Holdings, through its subsidiary Airobotics, has secured a service agreement for additional Optimus drone systems from a local government entity in Dubai. This agreement marks a significant expansion of Airobotics' operations in the region, showcasing the growing demand for drone technology solutions in governmental operations.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 12:53 pm

LKNCY

SBUX

YUMC

Yum China Holdings Inc. (NYSE:YUMC) has significantly accelerated its share repurchase program and restaurant expansion, surpassing the 15,000-store milestone in China. The company spent a record $745 million on share buybacks and dividends in Q1, buying back more shares than any year in its history and raising its quarterly dividend. Yum China is expanding into smaller cities with new store formats and franchising, and has launched a new coffee chain, KCOFFEE, to compete with Starbucks and Luckin. The company aims to serve half of China's population by 2026, with plans to open 1,500 to 1,700 new stores this year.

Portfolio Pulse from The Bamboo Works

May 01, 2024 | 12:48 pm

SNX

TD SYNNEX's subsidiary, Hyve Solutions, has been named a design partner for NVIDIA's HGX product line, indicating a strategic collaboration that could enhance TD SYNNEX's offerings in high-performance computing solutions.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 12:48 pm

VYNE

VYNE Therapeutics has presented positive preclinical and Phase 1b data for its novel BET inhibitor, VYN201, at the 2024 SID Annual Meeting, focusing on its application in nonsegmental vitiligo.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 12:45 pm